Literature DB >> 30100102

Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders.

Dan Lu1, Jia Song2, Yizhe Sun2, Fang Qi2, Liang Liu1, Yan Jin1, Michael A McNutt1, Yuxin Yin3.   

Abstract

Dysregulation of innate immunity accompanied by excessive interferon production contributes to autoimmune disease. However, the mechanism by which the immune response is modulated in autoimmune disorders is largely unknown. Here we identified loss-of-function mutations of OTUD1 associated with multiple autoimmune diseases. Under inflammatory conditions, inducible OTUD1 acts as an immune checkpoint and blocks RIG-I-like receptors signaling. As a deubiquitinase, OTUD1 directly interacts with transcription factor IRF3 and removes the K63-linked poly-ubiquitin chains on IRF3 Lysine 98, which inhibits IRF3 nuclear translocation and transcriptional activity. In contrast, OTUD1 mutants impair its suppressive effects on IRF3 via attenuating the OTUD1 deubiquinase activity or its association with IRF3. Moreover, we found FOXO3 signaling is required for OTUD1 induction upon antigenic stimulation. Our data demonstrate that OTUD1 is involved in maintaining immune homeostasis and loss-of-function mutations of OTUD1 enhance the immune response and are associated with autoimmunity.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Autoimmunity; Deubiquitinase; IRF3; Loss-of-function mutation; OTUD1

Mesh:

Substances:

Year:  2018        PMID: 30100102     DOI: 10.1016/j.jaut.2018.07.019

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  13 in total

1.  Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis.

Authors:  Hong-Guang Zhang; Bin Wang; Yong Yang; Xuan Liu; Junjie Wang; Ning Xin; Shifeng Li; Ying Miao; Qiuyu Wu; Tingting Guo; Yukang Yuan; Yibo Zuo; Xiangjie Chen; Tengfei Ren; Chunsheng Dong; Jun Wang; Hang Ruan; Miao Sun; Xingshun Xu; Hui Zheng
Journal:  Cell Res       Date:  2022-07-12       Impact factor: 46.297

Review 2.  Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses.

Authors:  Yujuan Chen; Junhong Lin; Yao Zhao; Xianping Ma; Huashan Yi
Journal:  J Zhejiang Univ Sci B       Date:  2021-08-15       Impact factor: 3.066

3.  The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling.

Authors:  Bo Wu; Lihua Qiang; Yong Zhang; Yesheng Fu; Mengyuan Zhao; Zehui Lei; Zhe Lu; Yan-Ge Wei; Hongmiao Dai; Yingwei Ge; Mingqiu Liu; Xuemei Zhou; Zhiqiang Peng; Hongchang Li; Chun-Ping Cui; Jing Wang; Hui Zheng; Cui Hua Liu; Lingqiang Zhang
Journal:  Cell Mol Immunol       Date:  2021-12-07       Impact factor: 11.530

Review 4.  The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity.

Authors:  Zhi Zong; Zhengkui Zhang; Liming Wu; Long Zhang; Fangfang Zhou
Journal:  Adv Sci (Weinh)       Date:  2020-12-15       Impact factor: 16.806

Review 5.  An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities.

Authors:  Guanghui Qian; Liyan Zhu; Gen Li; Ying Liu; Zimu Zhang; Jian Pan; Haitao Lv
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

6.  The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity.

Authors:  Jia Song; Tongtong Liu; Yue Yin; Wei Zhao; Zhiqiang Lin; Yuxin Yin; Dan Lu; Fuping You
Journal:  EMBO Rep       Date:  2021-01-04       Impact factor: 8.807

Review 7.  The Role of Deubiquitinating Enzymes in Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Tiao Li; Chunbin Zou
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

Review 8.  New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and Beyond.

Authors:  Erkan Demirkaya; Sezgin Sahin; Micol Romano; Qing Zhou; Ivona Aksentijevich
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241

Review 9.  The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?

Authors:  Min Zou; Qi-Shan Zeng; Jiao Nie; Jia-Hui Yang; Zhen-Yi Luo; Hua-Tian Gan
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

10.  CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis.

Authors:  Katherine B Hisert; Timothy P Birkland; Kelly Q Schoenfelt; Matthew E Long; Brenda Grogan; Suzanne Carter; W Conrad Liles; Edward F McKone; Lev Becker; Anne M Manicone; Sina A Gharib
Journal:  Front Pharmacol       Date:  2020-08-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.